A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 810 participants.
Also called NCT06589765
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 810 participants
- Registry
-
NCT06589765
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06589765. Randomized; double masking; primary purpose treatment. Start 2024-09-27 (actual); primary completion 2026-05-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- HRS-7535 tablet
- Intervention (Drug)
- dapagliflozin tablet
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct06589765- Content hash
6046d4abc3e6c0e9759426fccf28b064270af7c47932418aafb9a900160a1799